S100A9 Interaction with TLR4 Promotes Tumor Growth-Reference-Cited by-同舟云学术

S100A9 Interaction with TLR4 Promotes Tumor Growth

Published:2012-03-28 Issue:3 Volume:7 Page:e34207
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Källberg Eva,Vogl Thomas,Liberg David,Olsson Anders,Björk Per,Wikström Pernilla,Bergh Anders,Roth Johannes,Ivars Fredrik,Leanderson Tomas

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. Prostate cancer in a transgenic mouse.;NM Greenberg;Proc Natl Acad Sci U S A,1995

2. Application of the transgenic adenocarcinoma mouse prostate (TRAMP) model for pre-clinical therapeutic studies.;R Martiniello-Wilks;Anticancer Res,2003

3. Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapy.;P Wikstrom;Prostate,2005

4. Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunization.;E Degl'Innocenti;Eur J Immunol,2005

5. Myeloid-derived suppressor cell heterogeneity and subset definition.;E Peranzoni;Curr Opin Immunol,2010

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prototypical innate immune mechanism hijacked by leukemia-initiating mutant stem cells for selective advantage and immune evasion in Ptpn11-associated juvenile myelomonocytic leukemia;2024-08-02

2. Computational Deciphering of the Role of S100A8 and S100A9 Proteins and Their Changes in the Structure Assembly Influences Their Interaction with TLR4, RAGE, and CD36;The Protein Journal;2024-03-02

3. S100A8/A9: An emerging player in sepsis and sepsis-induced organ injury;Biomedicine & Pharmacotherapy;2023-12

4. CRISPR-Cas9 based knockout of S100A8 in mammary epithelial cells enhances cell proliferation and triggers oncogenic transformation via the PI3K-Akt pathway: Insights from a deep proteomic analysis;Journal of Proteomics;2023-09

5. Third generation quinoline‐3‐carboxamide transcriptional disrupter of HDAC4, HIF‐1α, and MEF‐2 signaling for metastatic castration‐resistant prostate cancer;The Prostate;2023-08-09